EQUITY Equity (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Foreign Currency Items |
|
Total |
|
(in thousands) |
| Balance at December 31, 2023 |
$ |
29,350 |
|
|
$ |
(1,900) |
|
|
$ |
27,450 |
|
Other comprehensive income (loss) before reclassifications |
11,382 |
|
|
(152,096) |
|
|
(140,714) |
|
| Amount reclassified from AOCI |
(9,492) |
|
|
— |
|
|
(9,492) |
|
| Net other comprehensive income (loss) |
1,890 |
|
|
(152,096) |
|
|
(150,206) |
|
| Balance at June 30, 2024 |
$ |
31,240 |
|
|
$ |
(153,996) |
|
|
$ |
(122,756) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
| Weighted average common shares—basic |
229,921,527 |
|
|
228,536,179 |
|
|
229,696,356 |
|
|
228,350,537 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
2,076,808 |
|
|
2,119,347 |
|
|
2,327,958 |
|
|
2,140,400 |
|
| Convertible senior notes |
13,004,660 |
|
|
13,004,660 |
|
|
— |
|
|
— |
|
| Weighted average common shares—diluted |
245,002,995 |
|
|
243,660,186 |
|
|
232,024,314 |
|
|
230,490,937 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Options to purchase shares of common stock |
3,750 |
|
|
3,750 |
|
|
3,750 |
|
|
3,750 |
|
| Restricted stock and deferred stock—unvested |
2,464,785 |
|
|
2,739,954 |
|
|
2,743,310 |
|
|
2,736,173 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
— |
|
|
— |
|
|
13,004,660 |
|
|
13,004,660 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
2,468,535 |
|
|
2,743,704 |
|
|
15,751,720 |
|
|
15,744,583 |
|
|